N/A
Completed N=200
A Prospective, Multi-Center Evaluation of Corneal Flap Creation Using Cheetah Femtosecond Laser System and Cheetah Patient Interface
Refractive Error
Source: ClinicalTrials.gov NCT03789669 ↗
Enrolled (actual)
200
Serious AEs
0.0%
Results posted
May 2025
Primary outcomePrimary: Stromal Bed Surface Quality — 0; 175 Eyes
Summary
The study is a prospective, open-label, comparative study design that was chosen for the purpose of optimizing the Cheetah settings, and evaluating the Cheetah system quality of LASIK flap.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Stromal Bed Surface Quality |
0; 175 | — |
Eligibility Criteria
INCLUSION CRITERIA
To be considered for enrollment of the study, subject must:
- Sign an informed consent and HIPAA authorization
- Be at least 18 years of age at the time of study exam
- Have refractive error and be eligible for commercial LASIK treatment
- Be available for all scheduled follow-up visits (see below)
EXCLUSION CRITERIA
Subject will not be eligible to take part of the study if subject, use or have:
- Known to be pregnant, breastfeeding or intend to become pregnant during the study.
- Recent ocular (eye) trauma or eye surgery
- A history of or active ophthalmic (eye) disease or abnormality
- Ocular hypertension (high eye pressure) with IOP (eye pressure) greater than 21 mmHg, glaucoma suspect, or are taking medications for these conditions
- A history or current diagnosis of any of the following medical conditions that could affect wound healing: collagen vascular disease, autoimmune disease, immunodeficiency disease, ocular herpes; endocrine disorders including, but not limited to unstable thyroid disorders and diabetes, lupus, and rheumatoid arthritis.
- Cardiac pacemaker, implanted defibrillator or other implanted electronic device
- Taking systemic or inhaled medications that may affect wound healing
- Known sensitivity or inappropriate responsiveness to any of the medications used in the study
- Desire for monovision correction
- Participating in any other clinical study
Data sourced from ClinicalTrials.gov (NCT03789669). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.